GLPwatch
Ongoing clinical trials evaluating the cardiovascular safety and efficacy of therapeutic approaches to diabetes mellitus.
Am J Cardiol · 2011
Last updated 2026-05-28Research shows people with type 2 diabetes have a higher risk of heart disease, and managing blood sugar and other health factors is important to reduce this risk. Several ongoing clinical trials are testing different diabetes treatments to see how well they work and how safe they are, especially for heart health. These studies aim to provide more information about the benefits of strict blood sugar control in people with diabetes who also have heart disease risk.
AI summary of the abstract below.
| Journal | Am J Cardiol, 2011 |
|---|---|
| Citations | 18 |
| Relative citation ratio | 0.54 |
| NIH percentile | 31 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Cardiovascular Risk Reduction |
Abstract
Research has substantiated that patients with type 2 diabetes mellitus are at increased risk for cardiovascular (CV) disease. It is well established that aggressive management of metabolic risk factors is critical to reducing morbidity and mortality in patients with diabetes. A number of clinical trials are currently focusing on evaluating the safety and efficacy of therapeutic approaches to diabetes. These trials will provide additional information on the role of aggressive management of glucose in patients with diabetes and CV risk. This article provides a summary of these ongoing trials, and discusses the impact of glycemic control and strategies to promote CV risk reduction in patients with diabetes.
Verbatim abstract via PubMed 21802581 ↗